Bendrofluazide

苄氟噻嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBendrofluazide
Drug Alias NamebendroflumetiazidabendroflumethiazidumBendroflumethiazideNaturetinAprinox +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsEdemaHypertensionKidney Calculi +[5] 
Global Approved IndicationsEdemaHypertensionKidney Calculi +[5] 
Approved Indications in ChinaEdemaHypertensionKidney Calculi +[4] 
Original Approved Country/TerritoryUnited States
Original Approved Date1959/12/07
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Shiji Pharmaceutical Co Ltd
Inactive CompaniesApothecon Llc
Active IndicationsEdemaHypertensionKidney Calculi +[4] 
Inactive IndicationsBronchial Spasm

Other Information

ATC CodeC03AA01
Related LinksWikipediaDrugBankKEGG